## Core Concept
Carcinoembryonic antigen (CEA) is a tumor marker commonly used in the management of colorectal cancer and other malignancies. It is a glycoprotein produced by certain cancer cells, and its levels can be elevated in patients with various types of cancer, including colorectal, lung, breast, and pancreatic cancer. CEA is not specific to any particular cancer and can also be elevated in benign conditions.

## Why the Correct Answer is Right
The correct answer, which is not provided, would typically relate to a statement that is true regarding carcinoembryonic antigen (CEA) and is an exception or an "except" (A/E) type question. Generally, CEA is used for monitoring disease recurrence, assessing response to treatment, and as a prognostic indicator. Its elevation is associated with a poorer prognosis in various cancers.

## Why Each Wrong Option is Incorrect
Without specific details on options A, B, C, and D, it's challenging to directly address each. However, we can discuss common misconceptions or incorrect statements about CEA:
- **Option A:** If a statement claims CEA is a specific marker for a particular cancer, it would be incorrect because CEA is not specific to any one type of cancer.
- **Option B:** If a statement suggests CEA is only used for diagnosis, it would be incorrect because CEA is primarily used for monitoring and prognosis.
- **Option C:** If a statement implies CEA levels are always elevated in cancer, it would be incorrect because CEA levels can be normal in some cancer patients and elevated in benign conditions.
- **Option D:** If a statement claims CEA is not useful in clinical practice, it would be incorrect because CEA has established utility in managing certain cancers.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while CEA can be elevated in various cancers, its levels can also be increased in smokers and in patients with benign conditions such as inflammatory bowel disease, liver disease, and pancreatitis. This lack of specificity makes CEA more useful for monitoring disease recurrence rather than for initial diagnosis.

## Correct Answer: D.